ASMB

18.30

3.21% 0.57

Dopo l'orario di chiusura: 18.38 0.08 +0.44%

Assembly Biosciences Inc (ASMB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$17.73

Aprire:

$17.79

Volume 24 ore:

49,284

Relative Volume:

1.97

Capitalizzazione di mercato:

$131.75M

Reddito:

Utile/perdita netta:

$-61.23M

Rapporto P/E:

-1.3536

EPS:

-13.5194

Flusso di cassa netto:

$22.49M

1 W Prestazione:

+5.72%

1M Prestazione:

+18.83%

6M Prestazione:

+6.71%

1 anno Prestazione:

+37.08%

Intervallo 1D:

$17.79

$18.77

Intervallo di 1 settimana:

$16.80

$18.92

Portata 52W:

$7.75

$19.93

Assembly Biosciences Inc Stock (ASMB) Company Profile

Nome

Assembly Biosciences Inc

Settore

Healthcare (1166)

Industria

Biotechnology (655)

Telefono

(833) 409-4583

Indirizzo

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-06

Ultimi documenti SEC

ASMB's Discussions on Twitter

Confronta ASMB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ASMB Assembly Biosciences Inc	18.30	131.75M	0	-61.23M	22.49M	-13.52
VRTX Vertex Pharmaceuticals Inc	457.03	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.74	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	329.77	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	545.11	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	244.32	28.51B	3.81B	-644.79M	-669.77M	-6.24

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-25	Iniziato	Guggenheim	Buy
2024-09-20	Aggiornamento	Jefferies	Hold → Buy
2021-09-13	Iniziato	H.C. Wainwright	Neutral
2021-09-02	Downgrade	William Blair	Outperform → Mkt Perform
2021-03-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-11-06	Downgrade	Jefferies	Buy → Hold
2020-10-19	Iniziato	Truist	Buy
2019-10-16	Iniziato	Mizuho	Buy
2018-11-19	Iniziato	Leerink Partners	Outperform
2018-10-08	Aggiornamento	B. Riley FBR	Neutral → Buy
2018-08-08	Iniziato	Robert W. Baird	Outperform
2018-04-13	Downgrade	Chardan Capital Markets	Buy → Neutral
2018-01-05	Iniziato	B. Riley FBR, Inc.	Neutral
2017-11-08	Iniziato	Jefferies	Buy
2017-05-30	Iniziato	Chardan Capital Markets	Buy

Mostra tutto

Assembly Biosciences Inc Borsa (ASMB) Ultime notizie

Jun 18, 2025

Where are the Opportunities in (ASMB) - news.stocktradersdaily.com

Jun 18, 2025

Jun 15, 2025

Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 47.1% in May - Defense World

Jun 15, 2025

Jun 10, 2025

Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research

Jun 10, 2025

Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World

Jun 10, 2025

Jun 09, 2025

Assembly Biosciences expands stock plans, appoints new CFO By Investing.com - Investing.com Nigeria

Jun 09, 2025

Assembly Biosciences expands stock plans, appoints new CFO - Investing.com

Jun 09, 2025

Assembly Biosciences Announces Stock Plan Amendments and Leadership Change - TipRanks

Jun 09, 2025

Assembly Biosciences IncJeanette M. Bjorkquist Appointed Principal Financial Officer On June 5- SEC Filing - MarketScreener

Jun 09, 2025

Jun 06, 2025

(ASMB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 06, 2025

Jun 01, 2025

Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares Sold by Northern Trust Corp - Defense World

Jun 01, 2025

May 31, 2025

When Will Assembly Biosciences, Inc. (NASDAQ:ASMB) Breakeven? - Yahoo Finance

May 31, 2025

Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Up 99.2% in May - Defense World

May 31, 2025

May 27, 2025

Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference | ASMB Stock News - GuruFocus

May 27, 2025

Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference - The Manila Times

May 27, 2025

Assembly Bio Leadership Team Set for Key Presentation at Major Jefferies Healthcare Conference - Stock Titan

May 27, 2025

Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics - Business Wire

May 27, 2025

May 21, 2025

Assembly’s NeosAI, Powered by Microsoft Azure AI Foundry, Sets New Benchmark for Legal Productivity—Backed by Real-World Results - GlobeNewswire Inc.

May 21, 2025

Mizuho Cuts Price Target on Assembly Biosciences to $29 From $36, Keeps Outperform Rating - marketscreener.com

May 21, 2025

May 15, 2025

ABI-4334 outperforms vebicorvir in HBV suppression - BioWorld MedTech

May 15, 2025

May 14, 2025

Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025

Growth Investors: Industry Analysts Just Upgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue Forecasts By 33% - simplywall.st

May 14, 2025

May 10, 2025

Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 10, 2025

Zacks Research Cuts Earnings Estimates for Las Vegas Sands - Defense World

May 10, 2025

May 09, 2025

Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register

May 09, 2025

Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times

May 09, 2025

Assembly Biosciences Reports Q1 2025 Earnings - TipRanks

May 09, 2025

May 08, 2025